Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders

This is the authors' abstract. We don't add key points for this paper.

There are currently no long-acting injectable antipsychotics (LAIAs) that are approved by the Food and Drug Administration for use in child and adolescent patients, however these agents are used off-label for the treatment of various psychiatric disorders. This study aims to describe the initiation and maintenance dosing strategies of LAIAs in child and adolescent psychiatry inpatients.